Identifying Biomarkers for Cervical Neoplasia: A Label-free Proteomic Analysis of Cervicovaginal Fluid
-
Published:2024-03-01
Issue:1
Volume:40
Page:36-43
-
ISSN:2651-3137
-
Container-title:European Archives of Medical Research
-
language:
-
Short-container-title:eamr
Author:
Köse BüşraORCID,
Takmaz ÖzgüçORCID,
Güngör MeteORCID,
Erkanlı SerkanORCID,
Koçak AlperORCID,
Serdar Muhittin A.ORCID,
Baykal Ahmet TarıkORCID
Publisher
Galenos Yayinevi
Reference30 articles.
1. 1. Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer 2007;12;2:15.
2. 2. Alrajjal A, Pansare V, Choudhury MSR, Khan MYA, Shidham VB. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System. Cytojournal 2021;17;18:16.
3. Detection of biomarkers in body fluids using bioprobes based on aggregation-induced emission fluorogens;Zhang;Mater Chem Front,2020
4. 4. Csősz É, Kalló G, Márkus B, Deák E, Csutak A, Tőzsér J. Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness. J Proteomics 2017;5;153:30-43.
5. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier;Borgdorff;Mucosal Immunol,2016